Register   |   Log In Contact Us
Or login with one of the following

Log in


Expanded criteria to identify men eligible for active surveillance of low-risk prostate cancer at Johns Hopkins: A preliminary analysis - Abstract

PURPOSE: The following eligibility criteria are used to enroll patients in active surveillance (AS) at Johns Hopkins: clinical stage T1, PSA density < 0.15, biopsy Gleason score ≤ 6, ≤ 2 positive biopsy cores, and ≤ 50% involvement of any biopsy core.

To continue reading this article, please Log In. If you do not have an account, please Register.